Plasma interleukin-11 (IL-11) levels have diagnostic and prognostic roles in patients with pancreatic cancer

Tumor Biology

Volumn 35, Issue 11, 2014, Pages 11467-11472

  Ren, Chuanli ^a,b   Chen, Yong ^a   Han, Chongxu ^a   Fu, Deyuan ^a   Chen, Hui ^a  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

IL 11; Pancreatic cancer; Plasma; Prognosis

Indexed keywords

INTERLEUKIN 11; TUMOR MARKER;

BLOOD; CANCER STAGING; CASE CONTROL STUDY; COMPARATIVE STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL RATE;

CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERLEUKIN-11; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PERITONEAL NEOPLASMS; PROGNOSIS; ROC CURVE; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84927799280     PISSN: 10104283     EISSN: None     Source Type: Journal    
DOI: 10.1007/s13277-014-2459-y     Document Type: Article

References (18)

1. Wolfgang CL, Herman JM, Laheru DA, Klein AP, Erdek MA, Fishman EK, et al. Recent progress in pancreatic cancer. CA Cancer J Clin. 2013;63:318–48.
2. Siveke JT, Crawford HC. KRAS above and beyond—EGFR in pancreatic cancer. Oncotarget. 2013;3:1262–3.
3. Shin SY, Choi C, Lee HG, Lim Y, Lee YH. Transcriptional regulation of the interleukin-11 gene by oncogenic Ras. Carcinogenesis. 2012;33:2467–76.
4. Garbers C, Scheller J. Interleukin-6 and interleukin-11: same but different. Biol Chem. 2013;394:1145–61.
5. Necula LG, Chivu-Economescu M, Stanciulescu EL, Bleotu C, Dima SO, Alexiu I, et al. IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in Gp130 subunits. J Gastrointest Liver Dis. 2012;21:23–9.
6. Tang D, Wang D, Yuan Z, Xue X, Zhang Y, An Y, et al. Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma. Int J Cancer. 2013;132:993–1003.
7. Gao YB, Xiang ZL, Zhou LY, Wu ZF, Fan J, Zeng HY, et al. Enhanced production of CTGF and IL-11 from highly metastatic hepatoma cells under hypoxic conditions: an implication of hepatocellular carcinoma metastasis to bone. J Cancer Res Clin Oncol. 2013;139:669–79.
8. Ernst M, Putoczki TL. Targeting IL-11 signaling in colon cancer. Oncotarget. 2013;4:1860–1.
9. Reitter EM, Ay C, Kaider A, Pirker R, Zielinski C, Zlabinger G, et al. Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients. Clin Exp Immunol. 2014;77:253–60.
10. Ren CL, Jin P, Han CX, Xiao Q, Wang DR, Shi L, et al. Unusual early-stage pancreatic sarcomatoid carcinoma. World J Gastroenterol. 2013;19:7820–4.
11. Dams-Kozlowska H, Gryska K, Kwiatkowska-Borowczyk E, Izycki D, Rose-John S, Mackiewicz A. A designer hyper interleukin 11 (H11) is a biologically active cytokine. BMC Biotechnol. 2012;12:8.
12. Taga T, Kishimoto T. Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997;15:797–819.
13. Onnis B, Fer N, Rapisarda A, Perez VS, Melillo G. Autocrine production of IL-11 mediates tumorigenicity in hypoxic cancer cells. J Clin Invest. 2013;123:1615–29.
14. Ellis M, Hedstrom U, Frampton C, Alizadeh H, Kristensen J, Shammas FV, et al. Modulation of the systemic inflammatory response by recombinant human interleukin-11: a prospective randomized placebo controlled clinical study in patients with hematological malignancy. Clin Immunol. 2006;120:129–37.
15. Calon A, Espinet E, Palomo-Ponce S, Tauriello DV, Iglesias M, Cespedes MV, et al. Dependency of colorectal cancer on a TGF-beta-driven program in stromal cells for metastasis initiation. Cancer Cell. 2012;22:571–84.
16. Yan D, Kc R, Chen D, Xiao G, Im HJ. Bovine lactoferricin-induced anti-inflammation is, in part, via up-regulation of interleukin-11 by secondary activation of STAT3 in human articular cartilage. J Biol Chem. 2013;288:31655–69.
17. Tas F, Karabulut S, Yasasever CT, Duranyildiz D. Serum transforming growth factor-beta 1 (TGF-beta1) levels have diagnostic, predictive, and possible prognostic roles in patients with melanoma. Tumour Biol. 2014;35:7233–7.
18. Bellone G, Smirne C, Mauri FA, Tonel E, Carbone A, Buffolino A, et al. Cytokine expression profile in human pancreatic carcinoma cells and in surgical specimens: implications for survival. Cancer Immunol Immunother. 2006;55:684–98.